Olmesartan API Market

Olmesartan API Market contains market size and forecasts of Olmesartan API in global, including the following market information:

• Global Olmesartan API Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Olmesartan API Market Sales, 2017-2022, 2023-2028, (Tons)
• Global top five Olmesartan API companies in 2021 (%)

The global Olmesartan API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Purity 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Olmesartan API include Coba Pharma, Acura Labs, Interquim, Euro API, Biophore India Pharmaceuticals, Jai Radhe, Summit Pharmaceuticals Europe, Octavius Pharma Pvt. Ltd and Zeon Health lndustries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Olmesartan API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Olmesartan API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Olmesartan API Market Segment Percentages, by Type, 2021 (%)

• Purity 99%
• Purity > 99%

Global Olmesartan API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Olmesartan API Market Segment Percentages, by Application, 2021 (%)

• Tablet Products
• Capsule Products
• Others

Global Olmesartan API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Olmesartan API Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Olmesartan API revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Olmesartan API revenues share in global market, 2021 (%)
• Key companies Olmesartan API sales in global market, 2017-2022 (Estimated), (Tons)
• Key companies Olmesartan API sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Coba Pharma
• Acura Labs
• Interquim
• Euro API
• Biophore India Pharmaceuticals
• Jai Radhe
• Summit Pharmaceuticals Europe
• Octavius Pharma Pvt. Ltd
• Zeon Health lndustries
• Sanofi
• Glenmark Pharmaceuticals Europe
• Verdant Pharma
• Hubei Yitai Pharmaceuticals
• Ulkar Kimya
• Zhejiang Tianyu Pharmaceutical
• Teva API
• Zhejiang Huahai Pharmaceutical
• Venkata Narayana Active Ingredients
• Cadila Pharmaceuticals
• Unimark Remedies
• Vasudha Pharma
• Macleods Pharmaceuticals
• Mylan